Disposable chromatography

BioPharm International

Volumn , Issue SUPPL., 2007, Pages 26-35

  Zhou, Joe X ^a   Tressel, Tim ^a   Guhan, Sam ^a  

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

ANTIBODY PRODUCTION; BIOTECHNOLOGY; CHROMATOGRAPHY; CLEANING; CONTAMINATION; COST EFFECTIVENESS ANALYSIS; DISPOSABLE CHROMATOGRAPHY; DISPOSABLE EQUIPMENT; DRUG INDUSTRY; DRUG MANUFACTURE; ECONOMIC ASPECT; FLOW RATE; LARGE SCALE PRODUCTION; PROCESS DEVELOPMENT; Q MEMBRANE CHROMATOGRAPHY; Q PACKED BED CHROMATOGRAPHY; RELIABILITY; REVIEW; SCALE UP; STORAGE; VALIDATION PROCESS; VALIDITY; VIRUS CLEARANCE;

EID: 33847094975     PISSN: 1542166X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Daemmrich A, Browden ME. A rising drug industry. Chem Eng News. 2005;6:28-42.
2. Walsh G. Biopharmaceuticals: approvals and approval trends in 2004. BioPharm Int. 2005;18(10):58-65.
3. Chadd HE, Chamow SM. Therapeutic antibody expression technology. Curr Opin Biotechnol. 2001;12:188-194.
4. Fahrner RL, Whitney DH, Vanderlaan M, Blank GS. Performance comparison of protein A affinity-chromatography sorbents for purifying recombinant monoclonal antibodies. Biotechnol Appl Biochem. 1999;30(2):121-8.
5. Fahrner RL. Industrial purification of pharmaceutical antibodies: development, operation, and validation of chromatography process. Biotechnol Gen Eng Rev. 2001;18:301-327.
6. Zhou J, Tressel T, Hong T, Solamo F, Dermawan S. Utilize current separation technology to achieve a cost-effective robust process for recombinant monoclonal antibody production. Antibody World Summit. Jersey City, NJ; 2005.
7. Tressel T. Development of a generic platform and use of statistically designed experiments to enable rapid development of several antibodies and increase throughput for first in human antibodies. Antibody production and downstream processing, IBC conference. San Diego, CA; 2004.
8. Knudsen H, Fahrner R, Xu Y, Norling L, Blank G. Membrane ion-exchange chromatography for process-scale antibody purification. J Chrom A. 2001;907:145-154.
9. Kemp G, O'Neil P. Large-scale production of therapeutic antibodies: considerations for optimizing product capture and purification. Antibodies (Subramanian G, Ed.). 2004; 1.2 vols, Plenum Publishers, New York.
10. Zhou J, Tressel T. Basic concepts in Q membrane chromatography for large-scale antibody production. Biotechnol Prog. 2006;22:341-349.
11. Zhou J, Tressel T. Q membrane chromatography as a robust purification unit for large-scale antibody production. Bioprocess Int. 2005;3:32-37.
12. Zhang R, Bouamama T, Tabur P, Zapata GA. Q membrane chromatography application for human antibody purification process. BioProduction. 2004; http://www.abgenix.com/documents/Bioproduction2004.pdf.
13. Deshmukh RR, et al. Large-scale purification of antisense oligonucleotides by high-performance membrane adsorber chromatography. J Chrom A. 2000;890:179-92.
14. Grunwald AG, Shields MS. Plasmid purification using membrane-based anion-exchange chromatography. Anal Biochem. 2001;296:138-41.
15. Zhang S, Krivosheyeva A, Nochumson S. Large-scale capture and partial purification of plasmid DNA using anion-exchange membrane capsules. Biotechnol Appl Biochem. 2003;37:245-9.
16. Teeters MA, Conrardy SE, Thomas BL, Root TW, Lightfoot EN. Adsorptive membrane chromatography for purification of plasmid DNA. J Chrom A. 2003;989:165-73.
17. Kuiper M, Sanches RM, Walford JA, Slater NK. Purification of a functional gene therapy vector derived from moloney murine leukaemia virus using membrane filtration and ceramic hydroxyapatite chromatography. Biotechnol Bioeng. 2002;80:445-53.
18. Specht R, et al. Densonucleosis virus purification by ion exchange membranes. Biotechnol Bioeng. 2004;88:465-73.
19. Gallher P, Fowler E. Validation of impurity removal by the CAMPATH-1H biomanufacturing process. IBC's Biopharmaceutical Production Week; 2001, http://www.sartorius.com/index.php?id=532&v=1&title=&year= &scale=&format=&membrane=&molecules=&type=.
20. Zhang R, et al. Viral clearance feasibility study with Sartobind Q membrane adsorber for human antibody purification. BioProduction; 2004, http://www.sartorius.de/en/biotechnology/laboratory/products_applications/ membrane_adsorbers/literature/pdfs/ Zhana_2004_Viral_clearance_feasabiltity_study_Sartobind_Q.pdf.
21. Zhou J, et al. Scale-down model design and viral clearance study of Q membrane for antibody process capacity. J Chrom A. 2006;1134:66-73.